Beam Therapeutics Inc.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

BEAM

organization

SIC: 2836

SEC Insider

$145.1M

610 transactions

Summary

Beam Therapeutics Inc. (BEAM) is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: —Sales: $128.5M26 insiders

Date	Insider	Type	Value
2026-06-26	FMR LLC	Sell	$8.9M
2026-06-25	FMR LLC	Sell	$1.2M
2026-04-01	Evans John M.(CEO)	Sell	$739K
2026-04-01	Ciaramella Giuseppe(President)	Sell	$290K
2026-04-01	Simon Amy(Chief Medical Officer)	Sell	$165K
2026-04-01	Bellon Christine(Chief Legal Officer)	Sell	$146K
2026-04-01	Cavanagh Bethany J(SVP, Finance and Treasurer)	Sell	$80K
2026-06-17	Ciaramella Giuseppe(President)	M	$30K
2026-03-31	Evans John M.(CEO)	M	$17K
2026-06-17	Ciaramella Giuseppe(President)	M	$4K
2033-06-06	Walsh Kathleen E	A	$0
2026-06-17	Ciaramella Giuseppe(President)	M	$0
2026-06-17	Ciaramella Giuseppe(President)	M	$0
2026-06-03	COOPER GRAHAM K	A	$0
2026-06-03	MARAGANORE JOHN	A	$0
2026-06-03	Walsh Kathleen E	A	$0
2026-06-03	Shaw Christi	A	$0
2026-06-03	Guindo Chirfi	A	$0
2026-06-03	Fishman Mark	A	$0
2026-03-31	Evans John M.(CEO)	M	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

Beam Therapeutics Inc. — Contributions, Lobbying & Contracts | Poliscope